BERINERT is used in adults and children to treat swelling and/or painful attacks of hereditary angioedema (HAE) affecting the abdomen, face or throat. The safety and efficacy of …

Berinert是C1酯酶抑制剂（人）的血浆衍生浓缩物，用于治疗成人和青少年患者的 遗传性血管性水肿（HAE） 的急性腹部或面部发作。 【使用限制】 预防性治疗的安全性和有效性尚未确定。 【作用机制】 C1 酯酶抑制剂通常在炎症过程中被激活，通过与反应位点共价结合使其底物失活。 C1 酯酶抑制剂是补体成分 1 (C1r) 亚成分 C1s、凝血因子 XIIa 和激肽释放酶的唯一已知抑制剂。 此外，C1 酯酶抑制剂是内在凝血级联中凝血因子 XIa 的主要抑制剂。 据推测，血管通透性增加和 …

Berinert is used to treat acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks in adults and children. It is given by intravenous injection by a healthcare provider although appropriately trained patients may self-administer it.

Indication: Treatment of acute abdominal or facial or laryngeal attacks of hereditary angioedema (HAE) in adult and adolescent patients. Product Information Package Insert - Berinert Supporting...

2016年8月17日 · Berinert是一种血浆C1磷脂抑制剂（人源），用来治疗儿童以及成人中由遗传性血管水肿引起的急性腹部、面部以及喉部的损害。 Berinert在预防HAE发作方面的安全性和疗效还未建立。 图片来源：http://www.berinert.com/ CSL Behring 的C1磷脂酶抑制剂Berinert在德国已上 …

BERINERT is the 1st and only plasma-derived on-demand HAE therapy with weight-based dosing. With BERINERT, patients can self-administer an appropriate dose when and where they need to.

Berinert 是血液中自然存在的一种蛋白质的人造形式，有助于控制体内的肿胀。 患有称为遗传性血管性水肿的患者体内这种蛋白质不足。 遗传性血管性水肿可能导致肿胀发作和诸如胃部问题或呼吸困难等症状。 Berinert 用于治疗遗传性血管性水肿患者。

BERINERT is a plasma-derived C1 Esterase Inhibitor (Human) indicated for the treatment of acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks in adult and pediatric patients. The safety and efficacy of BERINERT for prophylactic therapy have …

2021年9月21日 · See full prescribing information for BERINERT. For intravenous use. Freeze-Dried Powder for Reconstitution. Table 1.

BERINERT is a plasma-derived concentrate of C1 Esterase Inhibitor (Human), indicated for the treatment of acute abdominal, facial or laryngeal attacks of hereditary angioedema (HAE) in adult and pediatric patients.